Cuprous Pharmaceuticals Inc.

6 enregistrements totalisant 623,108.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Conseil national de recherches Canada $623,108 6 enregistrements

Enregistrements

Cuprous Pharmaceuticals Inc. $398,948.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2018-2019
Canada

The Firm has identified compositions that may be applicable to inducing cell death in a controlled manner. The Firm seeks to obtain proof-of-concent data with this project.

Cuprous Pharmaceuticals Inc. $57,704.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support

Cuprous Pharmaceuticals Inc. $40,656.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
EF 2020-2021
Canada

The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.

Cuprous Pharmaceuticals Inc. $21,676.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
EF 2020-2021
Canada

The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.

Cuprous Pharmaceuticals Inc. $20,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Youth Employment Program
EF 2020-2021
Canada

This project involves market research based on Cuprous’ Metaplex nanotechnology platform for drug delivery, lead generation and qualification, and customer discovery and outreach. The aim of the proje...